Proteome News and Research

RSS

The proteome is the entire complement of proteins expressed by a genome, cell, tissue or organism. More specifically, it is the expressed proteins at a given time point under defined conditions. The term is a blend of proteins and genome.

Blood proteins could help provide a comprehensive 'liquid health check' in future

Proteins in our blood could in future help provide a comprehensive 'liquid health check', assessing our health and predicting the likelihood that we will we will develop a range of diseases, according to research published today in Nature Medicine.

2 Dec 2019

“Liquid health check” could predict disease risk in the future

Measuring proteins in the blood could serve as a “liquid health check” that could predict people’s risk of developing diseases.

2 Dec 2019

Arrayjet secures new contract to provide SciLifeLab with microarray technology for proteomics research

Arrayjet, the Scottish-based microarray instrumentation company, has secured a GBP250,000 contract to provide the Swedish SciLifeLab - the national hub for molecular bioscience in Sweden - with microarray technology to provide further analytical information for mapping the human protein atlas.

29 Nov 2019

Applying a Proteomics-based Approach to the Clinic

Matthias Mann explains why applying proteomics-based technologies such as timsTOF could accelerate the diagnosis and prediction of human disease.

From Bruker Daltonics 20 Nov 2019

Proteomics & DIA Mass Spectroscopy in Neurodegenerative Disease Research

News-Medical Life Sciences spoke to Nicholas Dupuis from Biognosys at Neuroscience 2019 about proteomics & DIA mass spectroscopy in neurodegenerative disease research.

From Biognosys AG 19 Nov 2019

Researchers make major breakthrough in cell signalling

Researchers at the University of Liverpool have made a major breakthrough in the field of cell signalling.

4 Nov 2019

Discovery of human cell signaling systems using bioinformatics

There are many and various receptors on the surface of each human cell, which bind to specific molecules called ligands, to set off signals that modulate cell activity accordingly. These pathways are exploited by therapeutic drugs. In fact, one in three drugs makes use of receptors belonging to a single very large family – the GPCR (G protein receptor coupled receptor) family.

1 Nov 2019

Varied diets may be the cause for differences in human and non-human primate saliva

The study, published recently in Molecular Biology and Evolution, describes the discovery that human saliva is much more watery than the saliva of chimpanzees and gorillas.

31 Oct 2019

New signaling systems discovered in human cells

The human cell has a wide variety of receptors on its surface that many molecules and therapeutic drugs can bind to in order to activate signals inside the cell to regulate different physiological functions. GPCRs are the largest - and a very important - family of receptors on human cells.

31 Oct 2019

Stony Brook-led study reveals how proteome collapse process drives cell death and aging

Cells undergo natural aging and death, processes that impact a multitude of cellular factors. A new Stony Brook University-led study, to be published in PNAS, provides a biophysical model that reveals how damage accumulates in the shapes of cellular proteins with age and is a trigger to death.

16 Oct 2019

CANDO drug discovery platform focuses on finding new medications for mental illnesses

An estimated 46.6 million U.S. adults struggle with mental illnesses, such as anxiety disorder, according to the National Institute of Mental Health. About half of millennials and 75% of Gen-Zers report having quit jobs for mental health reasons.

15 Oct 2019

Atlas Antibodies presents QPrEST standards for absolute quantification of proteins using mass spectrometry

Atlas Antibodies AB, a leading supplier of advanced research reagents, announced today the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid chromatography (LC)–mass spectrometry (MS).

From Atlas Antibodies 16 Sep 2019

Cancer disease incidence and severity influenced by gene mutation, tissue location

The KRAS gene is one of the commonly mutated genes in cancer. More than 40 percent of colorectal cancers have a mutated KRAS gene, or oncogene, that is at least partially responsible for cancer development.

12 Sep 2019

CSIRO scientists can now detect gluten in any food

Scientists from Australia’s national science agency, CSIRO, can now detect gluten in any food and show which grain it comes from, making it easier for food companies to correctly label their products.

16 Aug 2019

New test reveals truth behind gluten-free labels

Many people have wondered whether the gluten-free labeling on their groceries was true. Now, scientists in Australia have come up with a way to identify the presence of specific glutens in rye that indicate the presence of this grain in foods labeled “gluten-free”. Gluten is already known to be present in wheat, barley and oats.

15 Aug 2019

Scientists discover hundreds of protein-pairs through coevolution study

Scientists have discovered hundreds of new protein-protein interactions by looking for co-evolution in some residues of aligned protein sequences.

15 Jul 2019

New alliance will focus on the structural visualization of novel druggable sites

PhoreMost has entered into an alliance with CCBT in India for the structural visualization of novel druggable sites across multiple targets.

From PhoreMost 8 Jul 2019

Intermittent fasting may protect against type 2 diabetes

Intermittent fasting is known to improve sensitivity to the blood glucose-lowering hormone insulin and to protect against fatty liver.

2 Jul 2019

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc, a pioneering drug discovery company, today announced they have signed a neurodegeneration drug discovery collaboration agreement.

From PhoreMost 25 Jun 2019

Muscle loss in space travelers could be reduced finds study

Researchers from the University of Texas Medical Branch at Galveston explain that space travellers often face muscle loss that is caused due to reduced gravity during their flight missions in space. They have found that exercise and certain hormones could help prevent this muscle loss.

13 Jun 2019

Proteome News and Research

Blood proteins could help provide a comprehensive 'liquid health check' in future

“Liquid health check” could predict disease risk in the future

Arrayjet secures new contract to provide SciLifeLab with microarray technology for proteomics research

Applying a Proteomics-based Approach to the Clinic

Proteomics & DIA Mass Spectroscopy in Neurodegenerative Disease Research

Researchers make major breakthrough in cell signalling

Discovery of human cell signaling systems using bioinformatics

Varied diets may be the cause for differences in human and non-human primate saliva

New signaling systems discovered in human cells

Stony Brook-led study reveals how proteome collapse process drives cell death and aging

CANDO drug discovery platform focuses on finding new medications for mental illnesses

Atlas Antibodies presents QPrEST standards for absolute quantification of proteins using mass spectrometry

Cancer disease incidence and severity influenced by gene mutation, tissue location

CSIRO scientists can now detect gluten in any food

New test reveals truth behind gluten-free labels

Scientists discover hundreds of protein-pairs through coevolution study

New alliance will focus on the structural visualization of novel druggable sites

Intermittent fasting may protect against type 2 diabetes

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

Muscle loss in space travelers could be reduced finds study

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Applying a Proteomics-based Approach to the Clinic

Proteomics & DIA Mass Spectroscopy in Neurodegenerative Disease Research

Latest News